XERS News and Press, Xeris Pharmaceuticals Inc. From 02/14/19

Motif Bio (NASDAQ: MTFB ) -75%  on receiving CRL from FDA. More news on: Motif Bio, Inovio Pharmaceuticals, Inc., Sierra Wireless, Inc., Stocks on the move, Read more ...

CHICAGO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced the pricing of the Compan...

Gainers:  CAS Medical Systems (NASDAQ: CASM ) +54% . Pyxus International (NYSE: PYX ) +23% . Gridsum Holding (NASDAQ: GSUM ) +22% . Ellie Mae (NYSEMKT: ELLI ) +21% . Tronox (NYSE: TROX ) +19% . Select Interior Concepts (NASDAQ: SIC ) +19% . Insignia Systems (NASDAQ: ISIG ) ...

CHICAGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that it filed a registrat...